We are pleased to announce the launch of an expanded assay development and screening facility at our headquarters in Chapel-en-le-Frice. The new 500 square meter facility builds on the company’s current integrated drug discovery capabilities and enhances support for the company’s global pharmaceutical and biotech customers.
Concept Life Sciences’ Assay Development and Screening Group provides tailored assay development and screening platforms for a wide range of therapeutic indications and modalities. This expansion will allow Drug Hunters to significantly reduce project schedules and costs, allowing programs to seamlessly progress throughout the drug discovery process.
This development builds on the company’s recent strategic expansion of its integrated drug discovery facility at its Chapelle-en-le-Frice site announced last year, which brought chemistry, ADMET and screening together under one roof.
Image credit: Concept Life Science
Concept Life Sciences continues to drive innovation in drug discovery with state-of-the-art facilities and a strong customer-centric approach. Expanding our assay development and screening capabilities strengthens our commitment to turning science into treatments that improve lives around the world.
Learn more about how our assay development and screening services can streamline drug discovery.
